French hospital data reveals rare disease burden
NCT ID NCT07222423
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 29 times
Summary
This study used French hospital records from 2015 to 2022 to estimate how many people have a group of rare genetic disorders called PROS. Researchers looked at over 3,600 patients to understand their age, sex, other health problems, and the costs of their care. The goal was to get a clearer picture of the disease's impact on patients and the healthcare system.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PIK3CA RELATED OVERGROWTH SPECTRUM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Novartis
East Hanover, New Jersey, 07936, United States
Conditions
Explore the condition pages connected to this study.